NSCI vs. DEST, SBTX, OPTI, ONC, SNG, OBI, IMM, HEMO, BVX, and GENF
Should you be buying NetScientific stock or one of its competitors? The main competitors of NetScientific include Destiny Pharma (DEST), SkinBioTherapeutics (SBTX), OptiBiotix Health (OPTI), Oncimmune (ONC), Synairgen (SNG), Ondine Biomedical (OBI), ImmuPharma (IMM), Hemogenyx Pharmaceuticals (HEMO), BiVictriX Therapeutics (BVX), and Genflow Biosciences (GENF). These companies are all part of the "biotechnology" industry.
NetScientific (LON:NSCI) and Destiny Pharma (LON:DEST) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, community ranking, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.
Destiny Pharma has a net margin of 0.00% compared to NetScientific's net margin of -221.55%. NetScientific's return on equity of -21.43% beat Destiny Pharma's return on equity.
4.3% of NetScientific shares are owned by institutional investors. Comparatively, 27.3% of Destiny Pharma shares are owned by institutional investors. 40.0% of NetScientific shares are owned by company insiders. Comparatively, 24.7% of Destiny Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
NetScientific has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Destiny Pharma has a beta of 0.31, suggesting that its share price is 69% less volatile than the S&P 500.
NetScientific has higher revenue and earnings than Destiny Pharma. NetScientific is trading at a lower price-to-earnings ratio than Destiny Pharma, indicating that it is currently the more affordable of the two stocks.
Destiny Pharma received 4 more outperform votes than NetScientific when rated by MarketBeat users. However, 69.61% of users gave NetScientific an outperform vote while only 60.48% of users gave Destiny Pharma an outperform vote.
In the previous week, Destiny Pharma had 1 more articles in the media than NetScientific. MarketBeat recorded 1 mentions for Destiny Pharma and 0 mentions for NetScientific. NetScientific's average media sentiment score of 0.00 equaled Destiny Pharma'saverage media sentiment score.
Summary
NetScientific and Destiny Pharma tied by winning 7 of the 14 factors compared between the two stocks.
Get NetScientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NSCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NetScientific Competitors List
Related Companies and Tools
